BDBM388642 Reboxe- tine::US9944618, Compound ID No. 178

SMILES CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1

InChI Key InChIKey=CBQGYUDMJHNJBX-RTBURBONSA-N

Data  6 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 388642   

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388642(Reboxe- tine | US9944618, Compound ID No. 178)
Affinity DataKi:  2.90nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388642(Reboxe- tine | US9944618, Compound ID No. 178)
Affinity DataKi:  39nMAssay Description:Displacement of [3H]-nisoxetine from human NET expressed in HEK293 cell membranes incubated for 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388642(Reboxe- tine | US9944618, Compound ID No. 178)
Affinity DataKi:  99.5nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetSodium-dependent dopamine transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388642(Reboxe- tine | US9944618, Compound ID No. 178)
Affinity DataKi:  5.26E+3nMAssay Description:DAT: This protocol was designed to measure inhibition of uptake by the human dopamine transporter. The reagents were human DAT (HEK293F) cells, GBR 1...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetVoltage-dependent calcium channel subunit alpha-2/delta-2(Human)
Esteve Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM388642(Reboxe- tine | US9944618, Compound ID No. 178)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]-gabapentin from human Cav alpha2delta2 expressed in HEK293 cell membranes incubated for 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1(Human)
Esteve Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM388642(Reboxe- tine | US9944618, Compound ID No. 178)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]-gabapentin from human Cav alpha2delta1 expressed in CHO-K1 cell membranes incubated for 60 mins by scintillation counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388642(Reboxe- tine | US9944618, Compound ID No. 178)
Affinity DataIC50:  1.80nMAssay Description:Inhibition of human NET expressed in HEK293 cells assessed as reduction in ASP+ uptake incubated for 20 mins before ASP+ addition and measured after ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed